Home Hexagon Bio

Hexagon Bio

In operation
Series C
Targeted Small Molecule Therapy Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Hexagon Bio is a data-driven biotechnology company dedicated to developing targeted small-molecule therapies. Hexagon Bio's proprietary platform combines data science and synthetic biology to discover and design drugs from DNA sequences. Hexagon Bio is mining fungal genomes for inspiration for the next generation of targeted therapies for unmet medical needs.
Hexagon Bio, Inc.
California,United States of America
15~50 people
January 01, 2016
info@hexagonbio.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Artificial Intelligence Targeted Technology Protein Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs ADC (Antibody-Drug Conjugate) AI+Pharmaceuticals